3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Conditions
Multiple Myeloma
265
Leukemia, Lymphocytic, Chronic, B-Cell
66
Lymphoma, Large B-Cell, Diffuse
60
Neoplasms, Plasma Cell
50
Lymphoma, Follicular
45
Lymphoma, Mantle-Cell
42
Lymphoma
41
Recurrence
38
Lymphoma, B-Cell, Marginal Zone
31
Leukemia
30
Leukemia, Myeloid, Acute
27
Lymphoma, B-Cell
19
Lymphoma, Non-Hodgkin
17
Myelodysplastic Syndromes
16
Waldenstrom Macroglobulinemia
15
Smoldering Multiple Myeloma
13
Hodgkin Disease
13
Lymphoma, T-Cell, Peripheral
12
Neoplasms
11
Lymphoma, T-Cell
9
Prostatic Neoplasms
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Lymphoma, T-Cell, Cutaneous
8
Immunoglobulin Light-chain Amyloidosis
8
Burkitt Lymphoma
8
Sezary Syndrome
7
Neoplasm, Residual
7
Mycosis Fungoides
7
Lymphoma, Large-Cell, Anaplastic
7
Leukemia, Plasma Cell
6
Interventions
fludarabine
9
Cytarabine
9
venetoclax
5
fludarabine phosphate
5
Cyclophosphamide
5
Busulfan
5
thymoglobulin
4
Tacrolimus
4
Sirolimus
4
Mycophenolic Acid
4
Methotrexate
4
Azacitidine
4
aldesleukin
3
Whole-Body Irradiation
3
Interleukin-2
3
Antilymphocyte Serum
3
asciminib
2
Thiotepa
2
Peripheral Blood Stem Cell Transplantation
2
Mitoxantrone
2
Idarubicin
2
Granulocyte Colony-Stimulating Factor
2
Filgrastim
2
Etoposide
2
Dasatinib
2
Cyclosporine
2
Bone Marrow Transplantation
2
Blood Specimen Collection
2
Behavior Therapy
2
zileuton
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Leukemia, Myeloid
×
Lenalidomide
×
Clear all
NCT02370888
2020-01-27
UF-BMT-MRD-101
University of Florida
Phase 1
Terminated
11 enrolled
3 charts